ArticleJournal of translational medicine2022

Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma.

Xinke Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.